Outcomes of cochlear implantation in patients with neurofibromatosis type 2

Hannah J D North, Deborah Mawman, Martin O'Driscoll, Simon R Freeman, Scott A Rutherford, Andrew T King, Charlotte Hammerbeck-Ward, D Gareth Evans, Simon K W Lloyd

Research output: Contribution to journalArticlepeer-review

Abstract

In neurofibromatosis type 2 (NF2) bilateral vestibular schwannomas (VS) or their treatment usually results in bilateral hearing loss. Cochlear implantation (CI) was traditionally not used in these patients due to concern that retrocochlear disease would render the implant ineffective. This paper describes the auditory outcomes of CI in 13 patients with NF2 and includes patients with untreated VS and patients undergoing VS removal with cochlear nerve preservation. The non-user rate was 7.7%. Of the active users, median CUNY score was 98%, median BKB score in quiet was 90% and median BKB score in noise was 68%. CI is a viable option in selected patients with NF2.

Original languageEnglish
Pages (from-to)172-177
Number of pages6
JournalCochlear Implants International
Volume17
Issue number4
Early online date3 Oct 2016
DOIs
Publication statusPublished - 2016

Keywords

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Audiometry, Pure-Tone
  • Cochlear Implantation/methods
  • Cochlear Implants
  • Cochlear Nerve/surgery
  • Female
  • Hearing/physiology
  • Hearing Loss, Bilateral/etiology
  • Humans
  • Male
  • Middle Aged
  • Neurofibromatosis 2/complications
  • Neuroma, Acoustic/etiology
  • Retrospective Studies
  • Speech Perception/physiology
  • Treatment Outcome
  • Young Adult

Fingerprint

Dive into the research topics of 'Outcomes of cochlear implantation in patients with neurofibromatosis type 2'. Together they form a unique fingerprint.

Cite this